We adopted R package to plot the Forest plot of this model, and found that the P values of ERAP2 and DOCK11 were both less than 0.05, suggesting that they could be independent prognostic factors for pancreatic cancer patients treated with gemcitabine, respectively (Figure 1C). Here, ERAP2 is linked to familial pancreatic carcinoma.